Compare ELUT & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELUT | OFS |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | United States | United States |
| Employees | N/A | 47 |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.3M | 46.2M |
| IPO Year | 2020 | N/A |
| Metric | ELUT | OFS |
|---|---|---|
| Price | $1.06 | $3.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 121.4K | 51.0K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 16.83% |
| EPS Growth | ★ 146.77 | N/A |
| EPS | ★ 0.87 | N/A |
| Revenue | ★ $12,293,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.83 | N/A |
| P/E Ratio | ★ $1.22 | $17.44 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.50 | $2.72 |
| 52 Week High | $2.60 | $9.31 |
| Indicator | ELUT | OFS |
|---|---|---|
| Relative Strength Index (RSI) | 48.85 | 35.02 |
| Support Level | $1.00 | $2.72 |
| Resistance Level | $1.18 | $4.40 |
| Average True Range (ATR) | 0.07 | 0.17 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 45.45 | 2.96 |
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to provide its stockholders with both current income and capital appreciation through debt investments and, to a lesser extent, equity investments.